Bupropion inhibits the cellular effects of nicotine in the ventral tegmental area
- 15 October 2007
- journal article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 74 (8), 1283-1291
- https://doi.org/10.1016/j.bcp.2007.07.034
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Chronic bupropion attenuated the anhedonic component of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shellEuropean Journal of Neuroscience, 2007
- The ventral tegmental area revisited: is there an electrophysiological marker for dopaminergic neurons?Journal Of Physiology-London, 2006
- Tolerance does not develop to the decrease in nicotine self‐administration produced by repeated bupropion administrationNicotine & Tobacco Research, 2005
- Nortriptyline for smoking cessation: A reviewNicotine & Tobacco Research, 2005
- Nicotinic Receptor Subtypes in Rat Hippocampal Slices Are Differentially Sensitive to Desensitization and Early in Vivo Functional Up-Regulation by Nicotine and to Block by BupropionThe Journal of pharmacology and experimental therapeutics, 2005
- Nicotine-like discriminative stimulus effects of bupropion in rats.Experimental and Clinical Psychopharmacology, 2002
- Nicotine-like discriminative stimulus effects of bupropion in rats.Experimental and Clinical Psychopharmacology, 2002
- Systemic nicotine‐induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental areaSynapse, 1994
- Personality measures as predictors of smoking initiation and cessation in the UNC Alumni Heart Study.Health Psychology, 1994
- Electrophysiological evidence for the existence of NMDA and non‐NMDA receptors on rat ventral tegmental dopamine neuronsSynapse, 1993